IL17A and hematocrit: TgAb, TPOAb, and some cytokines dysregulated in HT individuals, such as IL1β, IL6, IL17, IL23, tumor necrosis factor (TNF)-α, and IFN–γ, are key pathogenic factors contributing to BMD alterations [42,43].